Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU731586B2 - Process for synthesizing carbapenem side chain intermediates - Google Patents
[go: Go Back, main page]

AU731586B2 - Process for synthesizing carbapenem side chain intermediates - Google Patents

Process for synthesizing carbapenem side chain intermediates Download PDF

Info

Publication number
AU731586B2
AU731586B2 AU82821/98A AU8282198A AU731586B2 AU 731586 B2 AU731586 B2 AU 731586B2 AU 82821/98 A AU82821/98 A AU 82821/98A AU 8282198 A AU8282198 A AU 8282198A AU 731586 B2 AU731586 B2 AU 731586B2
Authority
AU
Australia
Prior art keywords
compound
accordance
formula
produce
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU82821/98A
Other versions
AU8282198A (en
Inventor
Michael S. Ashwood
Karel M. J. Brands
Mark Cameron
Ian F. Cottrell
Anthony J. Davies
Ulf H. Dolling
Ronald B. Jobson
John M. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810184.3A external-priority patent/GB9810184D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU8282198A publication Critical patent/AU8282198A/en
Application granted granted Critical
Publication of AU731586B2 publication Critical patent/AU731586B2/en
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. Request to Amend Deed and Register Assignors: MERCK & CO., INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)

Description

WO 99/02531 PCT/US98/13738 -1- TITLE OF THE INVENTION PROCESS FOR SYNTHESIZING CARBAPENEM SIDE CHAIN INTERMEDIATES BACKGROUND OF THE INVENTION The present invention relates to the synthesis of carbapenem side chains, and in particular, to side chains or portions thereof containing a pyrrolidine group, which is bonded to the carbapenem nucleus through a thioether linkage. Typically, the pyrrolidine is a portion of the side chain, and is substituted at the two position with any of a variety of substituents.
Conventionally, these intermediate compounds are prepared from a 4-hydroxyproline derivative of the formula:
HO
H CONRR 2
N
R
Such synthetic schemes typically require the extensive use of protecting groups.
Similarly, a method of converting trans-4-hydroxy-L-proline to a thiolactone of the formula: 0
S
N N
C(O)CH
3 has been described. However, this thiolactone is unsuitably protected for synthesis of carbapenem antibiotics.
WO 99/02531 PCTIUS98/13738 -2- EP 551 993 Al published on July 21, 1993 relates to a synthesis which utilizes active esterifying agents and base, followed by treatment with hydrogen sulfide, or an alkali metal salt of hydrogen sulfide, and base.
The present invention is an improvement over these other processes, utilizing a sulfide source which surprisingly improves the process when commercial quantities are synthesized.
SUMMARY OF THE INVENTION A process for synthesizing a compound of the formula 1: N 0
S
1 is described wherein P is a protecting group comprising reacting a compound of formula 2:
HO,,
N C0 2
H
P
2 wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of formula 3: WO 99/02531 PCT/US98/13738 reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4:
H
3 CS03/,// and combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
More particularly, the process described herein relates to a process for producing a compound of the formula WO 99/02531 PCT/US98/13738 -4wherein P is a protecting group; R1 and R 2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH 2 NHC1-4 alkyl, N(C1-4 alkyl)2, SO3H, CN, NHC(0)C 1 .4 alkyl, SO2NH 2 S02C 1-4 alkyl, aryl and heteroaryl; comprising: reacting a compound of the formula 2: HO N
CO
2
H
P
2 wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3:
HO,,,
N
OP
II
3 reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4: WO 99/02531 PCT/US98/13738
H
3 CS03 4 combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1: N'0
S
1 and reacting compound 1 with NHR1R2 wherein Ri and R 2 are as previously defined to produce a compound of formula DETAILED DESCRIPTION OF THE INVENTION The invention is described using the following definitions unless otherwise specified.
Alkyl and the alkyl portions of substituent groups include monovalent hydrocarbon chains containing from 1-4 carbon atoms which are straight or branched as appropriate.
Aryl refers to 6-10 membered mono- and bicyclic ring systems, containing carbon atoms with alternating (resonating) double bonds. Preferred aryl groups are phenyl and naphthyl.
Heteroaryl refers to aromatic 5-10 membered mono- and bicyclic ring systems, containing from 1-4 heteroatoms, 0, S or N.
WO 99/02531 PCT/US98/13738 -6- Preferred nitrogen containing monocyclic heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyrrolyl, imidazolyl, thiazolyl, oxazolyl and 1, 2, 4-triazolyl. Preferred heteroaryl groups containing oxygen as the only heterotom include furanyl. Preferred heteroaryl groups containing sulfur as the only heterotom include thienyl.
Preferred bicyclic heteroaryl groups include benzthiazolyl, benzimidazolyl, quinolinyl and isoquinolinyl, indolyl and isoindolyl.
When substituted, the aryl and heteroaryl groups may be substituted with 1-3 groups selected from the group consisting of: C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halo, hydroxy, CO2H, CO2C1- 4 alkyl,
NH
2
NHC
1 4 alkyl, N(C1- 4 alkyl)2, NHC(O)C 1 4 alkyl, SO3H, CN, SO2NH2, SO2C1-4 alkyl, aryl and heteroaryl.
When necessary, the substituents which are optionally present on aryl and heteroaryl can be in protected form.
Examples of suitable protecting groups include the following without limitation: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C- 1 o alkylphosphoryl, diarylphosphoryl and di-ar-C-o 10 alkylphosphoryl. Preferred silyl protecting groups are trimethylsilyl and triethylsilyl. Preferred carboxyl protecting groups are p-nitrobenzyl and allyl. Preferred phosphoryl based protecting groups include diisopropylphosphoryl.
Many other suitable hydroxyl and carboxyl protecting groups are known in the art. See, Greene, T. et al. Protective Groups in Organic Synthesis, John Wiley Sons, Inc., 1991.
P represents a protecting group on the proline nitrogen atom.
Thus, in one aspect of the invention, P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitro- WO 99/02531 PCT/US98/13738 -7benzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2-trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2-(trimethylsilyl) ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl, 4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-C,,10 alkylphosphoryl, diarylphosphoryl and di-ar-C.
10 o alkylphosphoryl.
More particularly, P represents a protecting group which is selected from the group consisting of: t-BOC, diisopropylphosphoryl and p-nitrobenzyloxycarbonyl.
Most particularly, P represents diisopropylphosphoryl.
Compound 2 used herein as a starting material is N protected trans-4-hydroxy-L-proline. The 2-carboxyl group is activated using the compound diphenylphosphinic chloride, which is reacted with compound II in a solvent in the presence of excess base. Solvents which are useful herein include dichloromethane, acetonitrile, toluene, fluorobenzene, tetrahydrofuran, or mixtures thereof. Bases which are useful for this reaction include trialkylamines. Preferred trialkylamines include diisopropylethylamine (DIPEA) and triethylamine.
Typically an amount of diphenylphosphinic chloride which is about equimolar to the starting compound can be used. The reaction between compound 2 and diphenylphosphinic chloride is typically run at reduced temperature, below about 0°C to as low as about -40 0
C.
Preferably, the reaction temperature is maintained at about Compound 3, with the diphenylphosphinyloxycarbonyl group at position two, is reacted with methanesulfonyl chloride (MsC1) to produce compound 4. This reaction is conducted in a solvent, in the presence of a slight molar excess of pyridine, collidine, lutidine and the like, using a slight molar excess of MsC1. This mesylation reaction may be conducted over about 1-4 hours, at a reduced temperature, about 0°C to as low as about -40°C. Preferably, the reaction temperature is maintained at about Compound 4 is thereafter combined with an alkali metal sulfide or non-alkali metal sulfide and water to form the thiolactone 1.
WO 99/02531 PCT/US98/13738 -8- Essentially the reaction can be conducted at about -10°C to about room temperature. Preferably the sulfide and water are added quickly, and the reaction is aged for several hours at ambient temperature.
As used herein, "alkali metal sulfide" refers to the group I metal sulfides, such as the sulfides of sodium and potassium. Preferably the alkali metal sulfide is Na 2
S.
As used herein, "non-alkali metal sulfides" and "alkaline earth metals" are used interchangeably to include the group II alkaline earth metal sulfides selected from the group consisting of: magnesium, calcium and barium. Preferred are calcium and barium.
The preferred non-alkali metal sulfide, most notably CaS, provides an unexpected advantage in that side products of the reaction have low solubility in water, and thus can be removed as a precipitate.
In a preferred aspect of the process described herein, the amine HNR'R 2 is m-aminobenzoic acid.
In another preferred aspect of the process, the compound of formula 5 is reacted with an acid to produce a compound of formula 6:
HH
6 More particularly, a compound of formula 2': H N -CO2H
N
P(O)(OiPr) 2 2' is reacted with diphenylphosphinic chloride to produce a compound of formula 3': WO 99/02531 PCT/US98/13738 -9- H O,, N CO 2 P(0)(Ph) 2
N
P(O)(OiPr) 2 3' compound 3' is reacted with mesyl chloride to produce compound 4': MsO,, C0 2 P(O)(Ph) 2
N
P(O)(OiPr) 2 4' compound 4' is reacted with a member selected from the group consisting of: Na 2 S, K 2 S, CaS and BaS to produce a compound of formula 1': (iPrO) 2 0 compound 1' is reacted with m-aminobenzoic acid to produce WO 99/02531 PCT/US98/13738
CO
2
H
HS
I N
[C(O)NH
P(O)(OiPr) 2 and compound 5' is reacted with acid to produce a compound of formula 6':
CO
2
H
HS
C(O)NH
N
H 6' or a salt or solvate thereof.
In a preferred aspect of the invention, the thiolactone compound 1 is reacted with the amine HNR'R 2 in the presence of an organic acid to produce compound 5. Examples of suitable organic acids include formic acid, acetic acid and propionic acid. Most preferably, the reaction is conducted in the presence of acetic acid.
After the conversion of compound 4' to compound the latter is combined with ammonia or a primary or secondary amine to form compounds of formula which can be deprotected to give compound 6' or salt thereof. In the isolation of 6' solvents, such as Ci.
alcohols, C.3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others may be added to improve crystallization, or otherwise facilitate isolation.
WO 99/02531 PCT/US98/13738 -11- Also, addition of a trialkyl or triaryl phosphine, tri-n-butylphosphine, at this stage may be useful in reducing the formation of disulfides corresponding to compound 6' and/or improving the rejection of other impurities.
Most primary and secondary amines HNR 1
R
2 wherein R 1 and/or R 2 represent H, aryl or heteroaryl react with compound 1 upon slight heating. Generally, the reaction proceeds from about RT to about 100 0 C over a few minutes to several hours.
The acid that is used to convert compound 5' to compound 6' can be varied within wide limits. For example, concentrated HC1 can be used and is preferred.
The invention described herein can be conducted in essentially a single reaction vessel, thus allowing for economical production of compounds 6' from compound 2.
The invention is further illustrated with the following nonlimiting examples.
EXAMPLE ONE (lS. 4S)-5-DIISOPROPYLPHOSPHORYL-2-THIA-5- AZABICYCLO[2.2.1 1HEPTAN-3-ONE
HO,
C diphenylphosphinic "C02H chloride P(O)(OiPr) 2 1-2
HO,
I I methanesulfonyl (CO Pchloride P(O)(OiPr) 2 WO 99/02531 PCT/US98/13738 -12- MsO,
O
CO-2 1-4 P(0)(OiPr) 2 CaS/H Slurry The following starting materials were utilized: Starting Material Quantity Diisopropylphosphoryl 5.0 g, 16.93 mmol hydroxyproline Diisopropylethylamine 6.34 mL, 36.44 mmol Diphenylphosphinic 3.36 mL, 17.61 mmol chloride Pyridine 1.48 mL, 18.29 mmol Methanesulfonyl chloride 1.43 mL, 18.46 mmol Calcium sulfide 1.49 g, 20.66 mmol Dichloromethane 100 mL Water 350 mL The mesylate mixed anhydride was formed according to WO 97/06154 published on February 20, 1997, incorporated herein by reference, and stirred with cooling at -15 0 C for 15 min.
Calcium sulfide (1.49 g) was added as a solid and washed with water (30 mL), resulting in a three phase reaction mixture. The mixture was stirred rapidly and the cooling bath removed, allowing the mixture to reach room temperature.
WO 99/02531 PCT/US98/13738 -13- The solids quickly went into solution, and a white solid precipitate was formed.
The mixture was stirred for 45 min and then filtered through a coarse filter. The solid on the filter was washed with dichloromethane and the filtrate separated.
The organic layer (approx. 200 mL) was washed with 1 M HC1 (50 mL), and 8% NaHCO 3 (50 mL). The aqueous bicarbonate layer was back extracted and the combined extracts were washed with brine and the layers weighed. The presence of the title compound (4.04 g) was confirmed by HPLC.
EXAMPLE TWO H O, OH diphenylphosphinic chloride CN *tX 2-2 0 I I 11"p/ methanesulfonyl chloride t-BOC WO 99/02531 WO 9902531PCT/US98/13738 -14- CaS
H
2 0 2-4 t-BOCIII A. Synthesis of tranSrN-t-butoxycarbonyl-2diphenylphosphinvloxycarbonyl-4-hydroxy-L-proline
HO,
DLPEA
IH dry THF 0
C
diphenyiphosphinic chloride t-BOC 2-2 A solution of compound 2-2 (35.0 g, 151 mmol.) and DIPEA m1L, 344 mmol) in dry THF (1.0 L) was combined over 20 min with a WO 99/02531 PCT/US98/13738 solution of diphenylphosphinic chloride (37.5 g, 155 mmol) in THF mL) at -20°C. The reaction mixture was stirred at -20 0 C for 90 minutes to produce compound 2-3, which can be isolated and characterized or used in the next part without isolation.
B. Synthesis of trans-N-t-butoxycarbonyl-2-diphenylphosphinyl oxvcarbonyl-4-methanesulfonyloxv-L-proline
HO,,
t-B MsOO methanesulfonyl chloride 2-3 2-4 Without isolation and characterization, after stirring the reaction mixture from part A for 90 minutes at -20 0 C, pyridine (13.0 mL, 161 mmol) was added followed by a solution of methanesulfonyl chloride (19.8 g, 171 mmol) in THF (50 mL) over 15 minutes. The reaction mixture was stirred at -20 0 C for 2 hours and allowed to warm to -5 0
C
over an additional 30 minutes producing compound 2-4. The methanesulfonyl substituted compound can be isolated and characterized, or used in the next reaction without isolation and characterization.
WO 99/02531 PCT/US98/13738 -16- C. Synthesis of N-t-butoxycarbonyl-2-thia-5-azabicyclo[2.2.1]heptan- 3-one CaS/H 2 0 Slurry t-BOC, i 2-1 After allowing the reaction from part B to warm to a slurry of CaS (45.0 g, 187 mmol) in H20 (60 mL) is added in one portion. The mixture is allowed to warm to room temperature and is stirred for 6 hrs. The resulting suspension is filtered and the filtrate is then partitioned between toluene and water. The organic layer is washed with HC1 (2.0 NaHCO3 (1.0 M) and brine, dried over MgSO4 and concentrated in vacuo.
EXAMPLE THREE t-BOC.
'C(O)NR
1
R
2 WO 99/02531 WO 9902531PCT/US98/13738 -17- The thiolactone 2-1 from Example Two without isolation, can be combined with the amnine shown below in column one to produce the cis N-protected 4-thiol substituted proline derivative shown below in column two.
TABLE ONE Amine Product (3) *6* (3-1) NH4LCl
'C(O)NH
2 t-bOC 3-5-1 (3-2)
NH
2 C(O)NH-Gj 3-5-2 1
C(O)NH-
C0 2
H
3-5-3 WO 99/02531 PCTIUS98/13738 -18- (3-4) HS C()NH s
CO
2
H
H
2 N S CO 2 H I t-BOC 3-5-4
HS
NH
2 S C(0)NH- N CO2H -COH k (O)(OiPr)2 3-5-5 4.0 eq. of NH 4 Cl in Et 3 N; solvent reaction time: 30 min at RT; 1.25 eq. of aniline; solvent toluene; reaction time: 2 hrs at 1OC; 1.25 eq. of 3-aminobenzoic acid; solvent toluene; reaction time: 2 hrs at 100 0
C;
1.25 eq. of 5-amino-2-carboxythiophene; solvent toluene; 2 hrs at 100 0
C;
P represents diisopropylphosphoryl. (iPr isopropyl).
EXAMPLE FOUR Using the procedures set forth in Example Two, Part A, the compounds of column one are reacted with diphenylphosphinic chloride to produce the compounds in column two.
WO 99/02531 WO 9902531PCT/US98/13738 -19- TABLE TWO I002 P(O) (Ph) 2 'C0 2
H
4-3-1 N0 2 N0 2 Ph phenyl 4-2-1 1 C0 2
H
CO
2 P(O) (Ph) 2 4-3-1 4-2-2 4-2-3 4-3-3
I
SUBSTITUTE SHEET (RULE 26) WO 99/02531 PCT/US98/13738 EXAMPLE FIVE Using the procedures set forth in Example One, Part B, the compounds of column one are reacted with methanesulfonyl chloride to produce the compounds in column two.
TABLE THREE 5-4-1 MsO, SC02P(0)(Ph) 2 4-3-1 N
OO-
NO
2 Ph phenyl 5-4-2 4-3-2 MsO,, Co 2 P(O)(Ph) 2 WO 99/02531 WO 99/253 1PCTIUS98/1 3738 -21- 5-4-3 4-.3-3 C -14WCO 2 P(O)(Ph) 2 EXAMPLE SIX Using the procedures set forth in Example Two, Part C, the compounds of column one are reacted with GaS in water to produce the compounds in column two.
FOUR
6-1-1 N0 2 5-4-1I 00
S
WO 99/02531 PCT/US98/13738 -22- 6-1-2 5-4-2 0 O N 0 6 S 6-1-3 5-4-3 0 0A ^0 EXAMPLE SEVEN Using the procedures set forth in Example Three, the compounds of column one are reacted with the amine in column two to produce the compounds in column three.
WO 99/02531 WQ 9902531PCTIUS98/13738 -23- 7-5-1 1 NH4CI 7-5-2 1
NH
2 C(O)NH-Ph N0 2 Ph Phenyl WO 99/02531 WO 9902531PCTIUS98/13738 -24- 7-5-4 1
HS
C(0)NH /s HN S, 0HN s C0 2
H
0^0
HS
6-1-2 C(O)NH 2 NH4C1 N 7-5-6 1
HS
6-1-2 NH 2 C(O)NH-Ph 00N Ph =Phenyl 7-5-7 1
HS
6-1-2 NH 2 C(0)NH\/
KN
0/0 C0 2
H
C0 2
H
WO 99/02531 WQ 9902531PCTIUS98/1 3738 I1 7-5-8 1 6-1-2 H2N /02H 7-.5..91
HS
C(O)NH
2 6-1-3 NH4CI 7-5-101
HS
NH
2 C(O)NH-Ph 6-1-3N =Phenyl 7-5-11 1
HS
613 NH 2 N C(O)NH -q C0 2
H
SC0 2
H
WO 99/02531 PCTIUS98/1 3738 -26- 7-5-12 1 HS4
)C(O)NH/\
6-1-3 H2CO 2 H HS N C()NH CO 2
H
(3) 7-5-13 1
NH
2 HS 1-1 N C()NH-
CO
2 H O CO 2
H
2H (O)(OiPr) 2 1: Tri-n-butylphosphine may be added.
While certain preferred embodiments have been described herein in detail, numerous alternative embodiments are contemplated as falling within the scope of the invention.

Claims (37)

1. A process for synthesizing a compound of the formula 1: wherein P is a protecting group, comprising reacting a compound of the formula 2: N CO 2 H I 2 wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3: D 0 WO 99/02531 PCT/US98/13738 -28- reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4: H 3 CS0 31 ,,6 H 3C0 03,,, No o P 0 4 ,and combining compound 4 with an alkali metal sulfide or non-alkali metal sulfide in water to produce a compound of formula 1.
2. A process of producing a compound of the formula HS C(O)NR'R 2 N P wherein P is a protecting group; R 1 and R 2 are independently selected from hydrogen, aryl and heteroaryl, said aryl and heteroaryl groups being unsubstituted or substituted with from 1-3 groups selected from the group consisting of: C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, halo, hydroxy, CO2H, CO2C1-4 alkyl, NH 2 NHC1-4 alkyl, N(C1-4 alkyl)2, SO3H, CN, NHC(O)C-4 alkyl, SO2NH2, S02C1-4 alkyl, aryl and heteroaryl; comprising: reacting a compound of the formula 2: WO 99/02531 PCT/US98/13738 -29- CO02H wherein P is as previously defined with diphenylphosphinic chloride to produce a compound of the formula 3: reacting compound 3 with methanesulfonyl chloride to produce a compound of formula 4: H3CSO3/,, N P r0 WO 99/02531 PCT/US98/13738 combining compound 4 with an alkali metal sulfide or non- alkali metal sulfide in water to produce a compound of formula 1: P O S 1 and reacting compound 1 with NHR 1 R 2 wherein RI and R 2 are as previously defined to produce a compound of formula
3. A process in accordance with claim 1 wherein P represents a member selected from the group consisting of: t-butylmethoxyphenylsilyl, t-butoxydiphenylsilyl, trimethylsilyl, triethylsilyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzyloxycarbonyl, t-butyloxycarbonyl (t-BOC), 2,2,2- trichloroethyloxycarbonyl benzhydryl, o-nitrobenzyl, p-nitrobenzyl, 2-naphthylmethyl, allyl, 2-chloroallyl, benzyl, 2,2,2-trichloroethyl, trimethylsilyl, t-butyldimethylsilyl, t-butyldiphenylsilyl, 2- (trimethylsilyl)ethyl, phenacyl, p-methoxybenzyl, acetonyl, p-methoxyphenyl,
4-pyridylmethyl, t-butyl, allyloxycarbonyl, di-CM-,O alkylphosphoryl, diarylphosphoryl and di-ar-C-,o alkylphosphoryl. 4. A process in accordance with claim 3 wherein P is selected from t-BOC, p-nitrobenzyloxycarbonyl and diisopropylphosphoryl.
5. A process in accordance with claim 4 wherein P represents diisopropylphosphoryl.
6. A process in accordance with claim 2 wherein 1 and NHR'R 2 are reacted to produce a compound of formula 5 in the presence of an organic acid. WO 99/02531 PCT/US98/13738 -31-
7. A process in accordance with claim 6 wherein the organic acid is selected from formic acid, acetic acid and propionic acid.
8. A process in accordance with claim 6 wherein 1 and NHR'R 2 are reacted in an organic solvent.
9. A process in accordance with claim 8 wherein the organic solvent is methylene chloride. A process in accordance with claim 1 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base.
11. A process in accordance with claim 3 wherein the base is a trialkylamine.
12. A process in accordance with claim 1-1 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine.
13. A process in accordance with claim 1 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base.
14. A process in accordance with claim 13 wherein the base is selected from the group consisting of pyridine, collidine and lutidine.
15. A process in accordance with claim 1 wherein compound 4 is reacted with a non-alkali metal sulfide to produce a compound of formula 1. WO 99/02531 PCT/US98/13738 -32-
16. A process in accordance with claim 15 wherein the non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10°C to about room temperature.
17. A process in accordance with claim 1 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p-nitrobenzyloxycarbonyl.
18. A process in accordance with claim 2 wherein compound 2 is reacted with diphenylphosphinic chloride in the presence of a base.
19. A process in accordance with claim 18 wherein the base is a trialkylamine. A process in accordance with claim 19 wherein the trialkylamine is selected from the group consisting of diisopropylethylamine and triethylamine.
21. A process in accordance with claim 2 wherein compound 3 is reacted with methanesulfonyl chloride to produce a compound of formula 4 in the presence of a base.
22. A process in accordance with claim 19 wherein the base is selected from the group consisting of pyridine, collidine and lutidine.
23. A process in accordance with claim 1 wherein the non-alkali metal sulfide in water is reacted with compound 4 to produce a compound of formula 1 at a temperature of about -10°C to about room temperature. WO 99/02531 PCT/US98/13738 -33-
24. A process in accordance with claim 2 wherein P represents t-butoxycarbonyl, diisopropylphosphoryl or p- nitrobenzyloxycarbonyl. A process in accordance with claim 2 wherein NHR 1 R 2 is selected from the group consisting of: NH 2 NH4C1, I H2N _C2 H SCO 2 H CO 2 H and
26. non-alkali metal magnesium. A process in accordance with claim 15 wherein the sulfide is selected from a sulfide of calcium, barium and
27. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of calcium sulfide.
28. A process in accordance with claim 26 wherein the non-alkali metal sulfide is comprised of barium sulfide.
29. A process in accordance with claim 1 wherein: P represents diisopropylphosphoryl and compound 4 is reacted with CaS in water to produce a compound of formula 1. A process in accordance with claim P represents diisopropylphosphoryl and compound 4 is in water to produce a compound of formula 1. 1 wherein: reacted with Na 2 S
31. A process in accordance with claim 2 wherein the amine HNR'R 2 is m-aminobenzoic acid. WO 99/02531 PCT/US98/13738 -34-
32. A process in accordance with claim 2, further comprising reacting a compound of formula 5 with an acid to produce a compound of formula 6: HS C(O)NR1R 2 N H
33. A process in accordance with claim 32 in which trialkyl or triarylphosphines is optionally added.
34. A process in accordance with claim 33 trialkylphosphine is tri-n-butylphosphine. in which the A process in accordance with claim 32 in which a solvent selected from the group consisting of C,. 5 alcohols, CI 3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others is optionally added.
36. A process in accordance with claim 2, wherein a compound of formula 2': ICO 2 H P(O)(OiPr) 2 2' is reacted with diphenylphosphinic chloride to produce a compound of formula 3': WO 99/02531 PCT/US98/13738 lC0 2 P()(Ph) 2 P(0)(OiPr) 2 3' compound 3' is reacted with mesyl chloride to produce a compound of formula 4': C0 2 P(0)(Ph) 2 N P(0)(OiPr) 2 compound 4' is reacted with a member selected from the group consisting of: Na 2 S, K 2 S, CaS and BaS to produce a compound of formula 1': (iPrO) 2 P(O) O compound 1' is reacted with m-aminobenzoic acid to produce WO 99/02531 PCT/US98/13738 -36- CO 2 H PN P(O)(OiPr)2 and compound 5' is reacted with acid to produce a compound of formula 6': C0 2 H HS ^N C(O)NH/ H 6' or a salt or solvate thereof.
37. A process in accordance with claim 32 in which trialkyl or triarylphosphines is optionally added.
38. A process in accordance with claim 33 trialkylphosphine is tri-n-butylphosphine. in which the
39. A process in accordance with claim 32 in which a solvent selected from the group consisting of C 1 5 alcohols, C,. 3 alkanoic acids, toluene, acetonitrile, ethyl acetate and others is optionally added. A process for synthesising azabicyclothiolactones, being substantially as hereinbefore described with reference to any one of examples 1, 2, or 4-6.
41. Azabicyclothiolactones prepared by the process of any one of claims 1, 10-17, 23, 26-30,
42. A process for synthesising N-protected 4-thiol substituted proline derivatives, being substantially as hereinbefore described with reference to any one of examples 3, 6 or 7.
43. N-protected 4-thiol substituted proline derivatives prepared according to the process of any one of claims 2, 6-9, 18-22, 24, 25, 31 -39, 42. io Dated 29 January, 2001 Merck Co., Inc. Patent Attorneys for the Applicant/Nominated Person SPRUSON FERGUSON 9 *9*e 9 I :\DayLib\LI BHI108394spec.doc:gcc
AU82821/98A 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates Ceased AU731586B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5203297P 1997-07-09 1997-07-09
US60/052032 1997-07-09
GB9810184 1998-05-13
GBGB9810184.3A GB9810184D0 (en) 1998-05-13 1998-05-13 Process for synthisizing carbapenem side chain intermediates
PCT/US1998/013738 WO1999002531A1 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Publications (2)

Publication Number Publication Date
AU8282198A AU8282198A (en) 1999-02-08
AU731586B2 true AU731586B2 (en) 2001-04-05

Family

ID=26313663

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82821/98A Ceased AU731586B2 (en) 1997-07-09 1998-07-02 Process for synthesizing carbapenem side chain intermediates

Country Status (5)

Country Link
EP (1) EP1019411A4 (en)
JP (1) JP2002504156A (en)
AU (1) AU731586B2 (en)
CA (1) CA2294342C (en)
WO (1) WO1999002531A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002492A1 (en) * 1997-07-10 1999-01-21 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
EP1261612A4 (en) * 2000-03-01 2003-04-02 Merck & Co Inc CRYSTALLINE SHAPES OF SIDE CHAIN CONTAINING ANTIBIOTIC INTERMEDIATES
TWI290925B (en) * 2000-11-20 2007-12-11 Sankyo Co Production of carbapenem antimicrobial agent
MX2007001713A (en) * 2004-08-11 2007-07-13 Donald L Barbeau Noncardiotoxic pharmaceutical compounds.
CN102264744A (en) * 2008-12-25 2011-11-30 株式会社钟化 Improved manufacturing method of carbapenem side chain intermediate
CN106565579A (en) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 Ertapenem side chain production technology
CN117304203A (en) * 2023-09-28 2023-12-29 郑州原理生物科技有限公司 A kind of preparation method of meropenem side chain intermediate thiol lactone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
JP3091297B2 (en) * 1992-01-10 2000-09-25 住友製薬株式会社 Pyrrolidine derivative and method for producing the same
JP3112952B2 (en) * 1995-08-04 2000-11-27 メルク エンド カンパニー インコーポレーテッド Method for synthesizing carbapenem side chain intermediate

Also Published As

Publication number Publication date
CA2294342C (en) 2006-03-14
JP2002504156A (en) 2002-02-05
EP1019411A4 (en) 2003-08-13
AU8282198A (en) 1999-02-08
EP1019411A1 (en) 2000-07-19
CA2294342A1 (en) 1999-01-21
WO1999002531A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
PL174601B1 (en) Carbapenemes containing phenyl group i and method of obtaining them
AU2007217795B2 (en) Processes for the convergent synthesis of calicheamicin derivatives
AU731586B2 (en) Process for synthesizing carbapenem side chain intermediates
WO2019229625A1 (en) Process for the preparation of apalutamide
CA2227696C (en) Process for synthesizing carbapenem side chain intermediates
US6063931A (en) Process for synthesizing carbapenem side chain intermediates
US6060607A (en) Process for synthesizing carbapenem side chain intermediates
US5574155A (en) Process for the synthesis of the disodium salt hemiheptahydrate of ceftriaxone
KR950013578B1 (en) Novel thiophosphate derivatives of novel thi (diazo) acetic acid and preparation method thereof
US5648501A (en) Process for synthesizing carbapenem side chain intermediates
GB2257703A (en) Acylation of 7 - amino-cephems
WO2024189550A1 (en) Process for the preparation of isavuconazonium sulfate and its crystalline forms
IE74167B1 (en) Solvates of a beta-lactam antibiotic
US5721368A (en) Process for synthesizing carbapenem side chain intermediates
KR101932824B1 (en) Intermediates and methods for synthesizing calicheamicin derivatives
PL145176B1 (en) Process for preparing derivatives of penemo-2-carboxylic-3-acid
KR20050075392A (en) Novel intermediate for carbapenem compound for oral administration and process for producing the same
JPH0656836A (en) Method for producing carbapenem derivative
CA2090921A1 (en) Process for preparing 1-[/2s/-methyl-3 -mercapto-propionyl]-pyrrolidine-/2s/-carboxylic acid
KR100650207B1 (en) Glutaryl 7-amino-3-vinyl-cephalosporanic acid derivatives and process for preparing it
US20060281918A1 (en) Resolution of enantiomeric mixtures of beta-lactams
HU192983B (en) Process for production of cefem compounds
JPS63179854A (en) Synthesis of bis(ethoxythiocarbonyl) sulfide
PL159170B1 (en) Method of obtaining semi-synthetic cephalosporins
WO2003000662A2 (en) Chiral preparation of a diastereomeric compound

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)